RadNet Stock News

Related Stocks: RDNT ,

Analysts expect RadNet, Inc. (NASDAQ:RDNT) to announce $0.19 earnings per share for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for RadNets earnings, with estimates ranging from $0.17 to $0.21. RadNet reported earnings of $0.20 per share during the same quarter last year, which would indicate a negative year over year growth []

Equities analysts expect that RadNet, Inc. (NASDAQ:RDNT) will post $347.96 million in sales for the current quarter, according to Zacks. Two analysts have provided estimates for RadNets earnings. The lowest sales estimate is $344.31 million and the highest is $351.61 million. RadNet posted sales of $308.50 million during the same quarter last year, which suggests []

RadNet (NASDAQ:RDNT) was upgraded by analysts at TheStreet from a c rating to a b- rating in a research note issued to investors on Wednesday, TheStreetRatingsTable reports. Other equities analysts have also recently issued reports about the stock. Barclays assumed coverage on shares of RadNet in a research note on Thursday, August 12th. They issued []

Zacks Investment Research upgraded shares of RadNet (NASDAQ:RDNT) from a hold rating to a buy rating in a research report released on Saturday, Zacks.com reports. They currently have $35.00 price objective on the medical research companys stock. According to Zacks, RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a []

Wall Street analysts forecast that RadNet, Inc. (NASDAQ:RDNT) will post earnings per share (EPS) of $0.19 for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for RadNets earnings, with the highest EPS estimate coming in at $0.21 and the lowest estimate coming in at $0.17. RadNet posted earnings of $0.20 []

LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting virtually during a fireside chat at the Jefferies 2021 London Healthcare Conference being held November 16-19, 2021. The fireside chat will be available to registered participants on-demand beginning at 8:00 a.m. GMT (12AM Pacific Time) on November 18, 2021.

LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and

RadNet, Inc. (RDNT) CEO Howard Berger on Q3 2021 Results - Earnings Call Transcript

RadNet (RDNT) delivered earnings and revenue surprises of 5.00% and -2.79%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

RadNet Inc (NASDAQ: RDNT) reports Q3 revenue of $332.7 million, +14% Y/Y, missing the consensus of $340.68 million. Aggregate procedural volumes increased 15.6%; Same-center procedural volumes incre

LOS ANGELES, Oct. 22, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and opera

LOS ANGELES, Oct. 08, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and opera

Grace Capital founder & CEO Catherine Faddis lays out her best investment ideas for Q4, including a pair of cybsecurity plays.

Despite the COVID-19 pandemic induced challenges, rising dependence on telehealth and AI's dominant role are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. EHC, RDNT and